1935
DOI: 10.1001/jama.1935.02760270015006
|View full text |Cite
|
Sign up to set email alerts
|

Functional Changes in Liver, Heart and Muscles, and Loss of Dextrose Tolerance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

1936
1936
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 36 publications
1
6
0
Order By: Relevance
“…DNP effectively reduced the weight of obese individuals but caused notable dysfunctions in the heart, liver, and other organs due to the accumulation of DNP in these organs. [45] According to our results, MN-TADNP treatment decreased DNP accumulation in the heart, liver, kidney, spleen, and lung to a minimal level, while there was relatively high organ accumulation of DNP for O-DNP-and O-TADNP-treated groups (Figure 3I-K; Figure S7, Supporting Information). Notably, the DNP content in heart tissue in the MN-TADNP-treated group was the lowest compared with oral DNP or TADNP treatment, suggesting that MN-TADNP treatment most effectively prevented the accumulation of DNP in the heart tissue, which is favorable for alleviating the cardiotoxicity of DNP.…”
Section: In Vivo Biodistribution Of Dnp After Oral and Microneedle De...supporting
confidence: 53%
“…DNP effectively reduced the weight of obese individuals but caused notable dysfunctions in the heart, liver, and other organs due to the accumulation of DNP in these organs. [45] According to our results, MN-TADNP treatment decreased DNP accumulation in the heart, liver, kidney, spleen, and lung to a minimal level, while there was relatively high organ accumulation of DNP for O-DNP-and O-TADNP-treated groups (Figure 3I-K; Figure S7, Supporting Information). Notably, the DNP content in heart tissue in the MN-TADNP-treated group was the lowest compared with oral DNP or TADNP treatment, suggesting that MN-TADNP treatment most effectively prevented the accumulation of DNP in the heart tissue, which is favorable for alleviating the cardiotoxicity of DNP.…”
Section: In Vivo Biodistribution Of Dnp After Oral and Microneedle De...supporting
confidence: 53%
“…In the 1930s, DNP was used clinically in humans as a treatment for obesity. However, its use was subsequently discontinued due to the occurrence of numerous deleterious side-effects at relatively high dosages (3-5 mg/kg body weight) (41,42). Such doses are ca.…”
Section: Discussionmentioning
confidence: 99%
“…T wave and ST segment abnormalities have been noted and some of the earlier autopsied case reports recorded heart muscle damage [46,50,53]. Gastroenteritis and anorexia have been reported in high doses [11,36].…”
Section: Organ Systems Affected By Therapeutic Usementioning
confidence: 98%